Combo Ipilimumab + Nivolumab in Histologies of Bladder Ca...

Combo Ipilimumab + Nivolumab in Histologies of Bladder Cancer
Don Photo

Don
3 anni 65 Visualizzazioni
Categoria:
Descrizione:
Bradley McGregor MD, Instructor, Medicine, Harvard Medical School, Clinical Director, Lank Center for Genitourinary Oncology, GU Network Liaison, Dana Farber Cancer Institute offers his insight on the combination of ipilimumab + nivolumab in histologies of bladder cancer.